July 6, 2017
Sequana Medical AG (“Sequana Medical), a commercial stage medical device company and an innovator in the management of liver disease, announces the publication of a multicentre, randomized controlled trial in the Journal of Hepatology. The study demonstrated that in patients with refractory ascites, the alfapump®: significantly reduces the requirement for LVP compared to standard of...
Read More